Nicolas Leupin, Former Chief Medical Officer at NovoCure Ltd (NVCR), sold 1,029 shares at $13.66 ($14K) on 2026-02-27, disclosed to the SEC on 2026-03-03.
Open-market sale of $14k NVCR by Former Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |